BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20877636)

  • 1. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
    Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
    PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates.
    Ng C; Jackson RA; Buschdorf JP; Sun Q; Guy GR; Sivaraman J
    EMBO J; 2008 Mar; 27(5):804-16. PubMed ID: 18273061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
    Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
    Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprouty proteins: modified modulators, matchmakers or missing links?
    Guy GR; Jackson RA; Yusoff P; Chow SY
    J Endocrinol; 2009 Nov; 203(2):191-202. PubMed ID: 19423641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
    Hu J; Hubbard SR
    J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
    Takeshita K; Tezuka T; Isozaki Y; Yamashita E; Suzuki M; Kim M; Yamanashi Y; Yamamoto T; Nakagawa A
    J Biochem; 2012 Nov; 152(5):487-95. PubMed ID: 22888118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.
    Mason JM; Morrison DJ; Bassit B; Dimri M; Band H; Licht JD; Gross I
    Mol Biol Cell; 2004 May; 15(5):2176-88. PubMed ID: 15004239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation.
    Lao DH; Yusoff P; Chandramouli S; Philp RJ; Fong CW; Jackson RA; Saw TY; Yu CY; Guy GR
    J Biol Chem; 2007 Mar; 282(12):9117-26. PubMed ID: 17255109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
    Okur MN; Russo A; O'Bryan JP
    Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
    Chandramouli S; Yu CY; Yusoff P; Lao DH; Leong HF; Mizuno K; Guy GR
    J Biol Chem; 2008 Jan; 283(3):1679-1691. PubMed ID: 17974561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK; Anderson SM
    J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
    Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
    J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
    Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
    EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor.
    Bartkiewicz M; Houghton A; Baron R
    J Biol Chem; 1999 Oct; 274(43):30887-95. PubMed ID: 10521482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
    de Melker AA; van der Horst G; Borst J
    J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.
    Fukazawa T; Miyake S; Band V; Band H
    J Biol Chem; 1996 Jun; 271(24):14554-9. PubMed ID: 8662998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding.
    Sun Q; Ng C; Guy GR; Sivaraman J
    FEBS Lett; 2011 Jan; 585(2):281-5. PubMed ID: 21163258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.